| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |